By utilizing The Cancer Genome Atlas (TCGA) database and analyzing clinical TNBC samples, Zhang et al. found that the expression of nicotinamide phosphoribosyltransferase antisense RNA (NAMPT-AS) was up-regulated, which epigenetically activates NAMPT to promote tumor progression and metastasis [176]. The gene discussed is NAMPT; the disease is neoplasm.